Earnings call transcript: InPost Q2 2026 revenue rises 18% as profit slips

InPost reported Q2 revenue of PLN 4.2bn (+18.2% YoY) and parcels of 381m (+16% YoY), but profitability deteriorated: adjusted EBIT fell 19.3% and adjusted net profit dropped 50% (adjusted EBITDA +4.4% to PLN 1,043m; margin down to ~25%). The company cut its 2026 adjusted EBITDA outlook to a mid-single-digit full-year decline and guided for continued negative free cash flow at year-end (H1 group FCF: -PLN 541m vs +PLN 54m a year earlier; net leverage rose to 2.5x). Shares were little changed at ~$15.53 (+0.06%), suggesting investors are balancing strong top-line growth and network expansion against weaker cash generation, higher CapEx (PLN 504m, +7% YoY), and the lowered earnings outlook.

Analysis

The key mechanism is not growth slowing; it is growth becoming more capital-intensive and less self-funding. When revenue still grows faster than volume but EBITDA margins, EBIT, and free cash flow all deteriorate, the market has to decide whether this is a scale story or a return-on-capital trap. At ~2.5x leverage and a negative cash conversion profile, InPost is now financing part of its own network expansion with balance-sheet risk, which raises the discount rate investors should apply to the international roll-up.

Second-order, the winners are likely the adjacent carriers that avoid this capex burden. If InPost pulls back on locker deployment or delays U.K. integration to protect cash, DHL/GLS/DPD-style operators and local last-mile providers can defend share in markets where density matters more than brand. The FedEx pilot is strategically interesting, but near term it reads more like an option value bridge than a P&L driver; the real benefit would be if it validates InPost as a white-label last-mile platform, which could partially offset margin pressure but also commoditize some of its network economics.

The contrarian point is that the consensus is still anchoring on volume share gains while underweighting how much of that share gain is now being bought with higher depreciation, financing costs, and working-capital drag. With the stock near a high and the multiple already rich, the downside asymmetry is from any further downgrade to cash flow or leverage, not from a small miss on parcels. Near term, the catalyst path is Q3 cash conversion and leverage; over 6-18 months, the question is whether the U.K. transformation ever becomes a margin contributor or just a perpetual reinvestment sink.

Key Decisions for Investors

• Short INPOY on strength over the next 1-3 weeks; the setup is a premium multiple against deteriorating EBIT/FCF and rising leverage. Use the 52-week high as the invalidation level; thesis breaks if Q3 shows clear cash flow recovery and leverage stabilizes below ~2.3x.
• Pair trade: long FDX / short INPOY for 3-6 months as quality-vs-capex intensity. FDX offers cleaner cash generation and lower balance-sheet stress; the spread should work if investors rotate away from self-funded growth stories. Cover the short if InPost re-accelerates margin without another CapEx increase.
• Avoid buying INPOY until management proves H2 free cash flow inflects positive. If the next update still shows negative FCF and leverage trending higher, expect multiple compression rather than growth premium expansion.
• Set an alert on INPOY for any guidance revision on CapEx or leverage. A cut to deployment plans or a surprise improvement in cash conversion would falsify the bearish thesis and could force a sharp short-covering rally.